Profile
| Metric | Value |
|---|---|
| Full Name | GoodRx Holdings, Inc. |
| Ticker | NASDAQ: GDRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | goodrx.com |
| Employees | 738 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $2.90 | |
| Price, 1D Change | +2.47% | |
| Market Cap | $984M | |
| - | ||
| PE Ratio | 33.76 | |
| Beta | 1.25 | |
| Revenue | $792M | |
| Revenue, 1Y Change | +5.61% | |
| EPS | $0.04 | |
| EPS, 1Y Change | +293.52% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.04 | |
| EPS Estimate | $0.36 | |
| EPS Est. Change | +761.24% | |
| Revenue | $792.32M | |
| Revenue Estimate | $794.70M | |
| Revenue Est. Change | +0.30% | |
| Current Price | $2.90 | |
| Price Target | - | $5.00 |
| Price Tgt. Change | - | +72.41% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.28 | -$0.02 | -107.71% | |
| $0.34 | $0.04 | -87.82% | |
| $0.36 | N/A | +761.24% | |
| $0.44 | N/A | +941.39% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $752.65M | $750.27M | -0.32% | |
| $793.54M | $792.32M | -0.15% | |
| $794.70M | N/A | +0.30% | |
| $818.97M | N/A | +3.36% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -36.12% | |
| Price, 3Y | -40.08% | |
| Market Cap, 1Y | -43.36% | |
| Market Cap, 3Y | -48.77% | |
| Revenue, 1Y | +5.61% | |
| Revenue, 3Y | +6.29% | |
| EPS, 1Y | +293.52% | |
| EPS, 3Y | +166.35% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $2.90 | |
| SMA 200 | $4.01 | |
| SMA 200 vs Price | +38.10% | |
| SMA 50 | $2.93 | |
| SMA 50 vs Price | +1.17% | |
| Beta | 1.25 | |
| ATR | $0.10 | |
| 14-Day RSI | 56.49 | |
| 10-Day Volatility | 27.88% | |
| 1-Year Volatility | 70.09% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $792.32M | |
| EPS | $0.04 | |
| Gross Profit | $674.57M | |
| Gross Margin | 85.14% | |
| Operating Profit | $89.29M | |
| Operating Margin | -3.59% | |
| Net Income | $16.39M | |
| Net Margin | 2.07% | |
| EBITDA | $158.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.75 | |
| Current Ratio | 5.32 | |
| Quick Ratio | 5.32 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 0.68 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 33.76 | |
| PS Ratio | 1.23 | |
| PB Ratio | 1.64 | |
| EV/EBITDA | 6.57 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $724.66M | |
| Cash & Equivalents | $448.35M | |
| Total Assets | $1.39B | |
| Current Assets | $659.26M | |
| Total Liabilities | $663.41M | |
| Current Liabilities | $123.90M | |
| Total Debt | $543.39M | |
| Short Term Debt | $10.64M | |
| Accounts Payable | $14.14M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $775.93M | |
| Operating Expenses | $585.28M | |
| Cost Of Goods Sold | $117.75M | |
| SG&A | $0.00 | |
| D&A | $69.54M | |
| Interest Expense | $0.00 | |
| Income Tax | $15.07M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $183.89M | |
| CFI | -$70.35M | |
| CFF | -$337.50M | |
| Capex | $70.35M | |
| Free Cash Flow | $113.55M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Morgan Stanley | → | |
| Barclays | ||
| JP Morgan | → | |
| TD Cowen | → | |
| UBS | → | |
| Mizuho | → | |
| UBS | → | |
| UBS | → | |
| Goldman Sachs | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with GDRX
Data Sources & References
- GDRX Official Website www.goodrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1809519/000180951925000143/0001809519-25-000143-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1809519/000180951925000040/0001809519-25-000040-index.htm
- GDRX Profile on Yahoo Finance finance.yahoo.com/quote/GDRX
- GDRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gdrx
FAQ
What is the ticker symbol for GoodRx Holdings, Inc.?
The ticker symbol for GoodRx Holdings, Inc. is NASDAQ:GDRX
Does GoodRx Holdings, Inc. pay dividends?
No, GoodRx Holdings, Inc. does not pay dividends
What sector is GoodRx Holdings, Inc. in?
GoodRx Holdings, Inc. is in the Healthcare sector
What industry is GoodRx Holdings, Inc. in?
GoodRx Holdings, Inc. is in the Health Information Services industry
What country is GoodRx Holdings, Inc. based in?
GoodRx Holdings, Inc. is headquartered in United States
When did GoodRx Holdings, Inc. go public?
GoodRx Holdings, Inc. initial public offering (IPO) was on September 23, 2020
Is GoodRx Holdings, Inc. in the S&P 500?
No, GoodRx Holdings, Inc. is not included in the S&P 500 index
Is GoodRx Holdings, Inc. in the NASDAQ 100?
No, GoodRx Holdings, Inc. is not included in the NASDAQ 100 index
Is GoodRx Holdings, Inc. in the Dow Jones?
No, GoodRx Holdings, Inc. is not included in the Dow Jones index
When was GoodRx Holdings, Inc. last earnings report?
GoodRx Holdings, Inc.'s most recent earnings report was on November 4, 2025
When does GoodRx Holdings, Inc. report earnings?
The next expected earnings date for GoodRx Holdings, Inc. is February 26, 2026